Quest Diagnostics (NYSE: DGX) announced its Q4 earnings on February 10, 2026, beating estimated earnings per share (EPS) by 2.98% with $2.42 against an estimate of $2.35. The company’s revenue also increased by $185.00 million compared to the previous year. Historically, beating EPS estimates has sometimes been followed by a slight drop in share price the next day.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Earnings Breakdown: Quest Diagnostics Q4
Quest Diagnostics (NYSE: DGX) announced its Q4 earnings on February 10, 2026, beating estimated earnings per share (EPS) by 2.98% with $2.42 against an estimate of $2.35. The company’s revenue also increased by $185.00 million compared to the previous year. Historically, beating EPS estimates has sometimes been followed by a slight drop in share price the next day.